Overview

A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease

Status:
Completed

Trial end date:
2024-02-14

Target enrollment:

Participant gender:

Summary

Investigator-initiated, interventional, prospective study to assess the clinical and operational effectiveness of daprodustat in adult patients receiving in center hemodialysis or peritoneal home dialysis who are transitioning from Mircera to daprodustat.

Phase:

Phase 4

Details

Lead Sponsor:

USRC Kidney Research

Collaborator:

GlaxoSmithKline